Chen, Yingxi http://orcid.org/0000-0002-3565-1052
Hu, Nan
Liao, Linda
Yu, Kai
Shu, Xiao-Ou
Zheng, Wei
Yuan, Jian-Min
Koh, Woon-Puay
Qiao, You-Lin
Fan, Jin-Hu
Dawsey, Sanford M.
Freedman, Neal D.
Taylor, Philip R.
Goldstein, Alisa M.
Abnet, Christian C.
Funding for this research was provided by:
National Institutes of Health
Article History
Received: 12 October 2020
Accepted: 10 May 2021
First Online: 22 May 2021
Declarations
:
: The Shanxi UGI Cancer Genetics Project (registered at ClinicalTrials.gov as NCT00341276) was approved by Shanxi Cancer Hospital and Institute Institutional Review Board and the NCI Special Studies Institutional Review Board. The Linxian Nutrition Intervention Trials (registered at ClinicalTrials.gov as NCT00342654) was approved by Cancer Institute of the Chinese Academy of Medical Sciences Institutional Review Board and the NCI Special Studies Institutional Review Board. The Shanghai Women’s and Men’s Health Study were approved by the Institutional Review Boards of Vanderbilt University and the Shanghai Cancer Institute. The Singapore Chinese Health Study was approved by the institutional review boards at the National University of Singapore and the University of Minnesota. All subjects provided informed consent. The current study was a secondary analysis of de-identified data.
: Not applicable.
: The authors declare that they have no competing interests.